Medtronic Garners Bilateral Activa Medicare Reimbursement In 33 States
This article was originally published in The Gray Sheet
Executive Summary
Medtronic Neurological President Scott Ward acknowledges that current off-label use of the company's Activa deep brain stimulation device for the bilateral treatment of Parkinson's tremor may dampen sales expectations once FDA approves the indication.